West Pharmaceutical Services (WST) Stock: Charts & Financials

West Pharmaceutical Services, Inc. (WST)WSTWest Pharmaceutical Services, Inc.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA

10,800 employees

www.westpharma.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Eric Green

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Total Current Assets	1.81B	1.81B	1.83B	1.98B	1.82B	1.68B	1.46B	1.54B	1.55B
Cash & Cash Equivalents	435.80M	435.80M	521.40M	791.30M	628.50M	509.70M	404.20M	484.60M	490.90M
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	435.80M	435.80M	521.40M	791.30M	628.50M	509.70M	404.20M	484.60M	490.90M
Accounts Receivable	712.00M	712.00M	685.60M	574.40M	625.00M	582.40M	543.60M	552.50M	524.30M
Inventory	447.40M	447.40M	452.60M	443.90M	438.00M	421.10M	388.70M	377.00M	401.20M
Total Assets	4.08B	4.08B	4.11B	4.27B	4.11B	3.95B	3.62B	3.64B	3.68B
Property, Plant & Equipment	3.35B	3.35B	3.33B	1.84B	1.84B	1.83B	1.74B	1.69B	1.68B
Goodwill	108.70M	108.70M	109.20M	110.00M	110.60M	110.90M	107.50M	106.10M	108.80M
Intangible Assets	6.40M	6.40M	7.00M	7.70M	8.90M	9.70M	10.00M	10.80M	12.30M
Long-Term Investments	207.70M	207.70M	209.20M	212.30M	220.90M	224.70M	211.90M	202.10M	217.50M
Total Current Liabilities	640.50M	640.50M	674.00M	654.90M	635.40M	604.60M	526.70M	550.40M	516.50M
Accounts Payable	252.70M	252.70M	252.30M	253.70M	255.80M	239.00M	228.40M	239.30M	224.30M
Short-Term Debt	20.90M	20.90M	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	1.09B	1.09B	1.12B	1.09B	1.05B	1.02B	935.10M	961.10M	923.00M
Long-Term Debt	291.20M	291.20M	202.80M	202.80M	202.70M	202.60M	202.60M	202.60M	202.60M
Total Debt	312.10M	312.10M	316.20M	321.10M	297.60M	303.30M	303.20M	302.30M	304.80M
Net Debt (Cash)	-123.70M	-123.70M	-205.20M	-470.20M	-330.90M	-206.40M	-101.00M	-182.30M	-186.10M
Total Shareholders' Equity	2.99B	2.99B	2.99B	3.18B	3.05B	2.93B	2.68B	2.68B	2.75B
Common Stock	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M
Retained Earnings	4.62B	4.62B	4.48B	4.37B	4.26B	4.14B	4.03B	3.96B	3.86B
Current Ratio	2.82	2.82	2.71	3.02	2.87	2.78	2.77	2.79	3.00
Debt to Equity Ratio	0.10	0.10	0.11	0.10	0.10	0.10	0.11	0.11	0.11

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Total Current Assets

1.81B

1.83B

1.98B

1.82B

1.68B

1.46B

1.54B

1.55B

Cash & Cash Equivalents

435.80M

521.40M

791.30M

628.50M

509.70M

404.20M

484.60M

490.90M

Short-Term Investments

0.00

Cash & Short-Term Investments

435.80M

521.40M

791.30M

628.50M

509.70M

404.20M

484.60M

490.90M

Accounts Receivable

712.00M

685.60M

574.40M

625.00M

582.40M

543.60M

552.50M

524.30M

Inventory

447.40M

452.60M

443.90M

438.00M

421.10M

388.70M

377.00M

401.20M

Total Assets

4.08B

4.11B

4.27B

4.11B

3.95B

3.62B

3.64B

3.68B

Property, Plant & Equipment

3.35B

3.33B

1.84B

1.83B

1.74B

1.69B

1.68B

Goodwill

108.70M

109.20M

110.00M

110.60M

110.90M

107.50M

106.10M

108.80M

Intangible Assets

6.40M

7.00M

7.70M

8.90M

9.70M

10.00M

10.80M

12.30M

Long-Term Investments

207.70M

209.20M

212.30M

220.90M

224.70M

211.90M

202.10M

217.50M

Total Current Liabilities

640.50M

674.00M

654.90M

635.40M

604.60M

526.70M

550.40M

516.50M

Accounts Payable

252.70M

252.30M

253.70M

255.80M

239.00M

228.40M

239.30M

224.30M

Short-Term Debt

20.90M

0.00

Total Liabilities

1.09B

1.12B

1.09B

1.05B

1.02B

935.10M

961.10M

923.00M

Long-Term Debt

291.20M

202.80M

202.70M

202.60M

Total Debt

312.10M

316.20M

321.10M

297.60M

303.30M

303.20M

302.30M

304.80M

Net Debt (Cash)

-123.70M

-205.20M

-470.20M

-330.90M

-206.40M

-101.00M

-182.30M

-186.10M

Total Shareholders' Equity

2.99B

3.18B

3.05B

2.93B

2.68B

2.75B

Common Stock

18.80M

Retained Earnings

4.62B

4.48B

4.37B

4.26B

4.14B

4.03B

3.96B

3.86B

Current Ratio

2.82

2.71

3.02

2.87

2.78

2.77

2.79

3.00

Debt to Equity Ratio

0.10

0.11

0.10

0.11

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	1.98B	1.54B	1.94B	1.92B	1.74B	1.37B	1.06B	894.40M
Cash & Cash Equivalents	791.30M	484.60M	853.90M	894.30M	762.60M	615.50M	439.10M	337.40M
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	791.30M	484.60M	853.90M	894.30M	762.60M	615.50M	439.10M	337.40M
Accounts Receivable	574.40M	552.50M	512.00M	507.40M	489.00M	385.30M	319.30M	288.20M
Inventory	443.90M	377.00M	434.70M	414.80M	378.40M	321.30M	235.70M	214.50M
Total Assets	4.27B	3.64B	3.83B	3.62B	3.31B	2.79B	2.34B	1.59B
Property, Plant & Equipment	1.84B	1.69B	1.51B	1.26B	1.13B	1.01B	909.40M	822.00M
Goodwill	110.00M	106.10M	108.50M	107.30M	109.90M	111.10M	107.80M	105.80M
Intangible Assets	7.70M	10.80M	15.10M	18.40M	23.00M	30.50M	29.80M	20.40M
Long-Term Investments	212.30M	202.10M	210.00M	204.90M	207.70M	214.70M	192.70M	91.20M
Total Current Liabilities	654.90M	550.40M	671.80M	519.00M	594.10M	503.40M	341.60M	283.70M
Accounts Payable	253.70M	239.30M	242.40M	215.40M	232.20M	213.10M	156.80M	130.40M
Short-Term Debt	22.70M	18.80M	134.00M	2.20M	44.20M	2.30M	2.30M	100K
Total Liabilities	1.09B	961.10M	948.50M	931.90M	978.40M	939.30M	768.20M	582.60M
Long-Term Debt	298.40M	202.60M	72.80M	206.70M	208.80M	252.90M	255.00M	196.00M
Total Debt	416.70M	305.30M	309.00M	317.90M	325.30M	325.70M	329.30M	196.10M
Net Debt (Cash)	-374.60M	-179.30M	-544.90M	-576.40M	-437.30M	-289.80M	-109.80M	-141.30M
Total Shareholders' Equity	3.18B	2.68B	2.88B	2.68B	2.34B	1.85B	1.57B	1.40B
Common Stock	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M	18.80M
Retained Earnings	4.37B	3.96B	3.52B	2.99B	2.46B	1.85B	1.55B	1.35B
Current Ratio	3.02	2.79	2.88	3.70	2.93	2.73	3.10	3.15
Debt to Equity Ratio	0.13	0.11	0.11	0.12	0.14	0.18	0.21	0.14

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

1.98B

1.54B

1.94B

1.92B

1.74B

1.37B

1.06B

894.40M

Cash & Cash Equivalents

791.30M

484.60M

853.90M

894.30M

762.60M

615.50M

439.10M

337.40M

Short-Term Investments

0.00

Cash & Short-Term Investments

791.30M

484.60M

853.90M

894.30M

762.60M

615.50M

439.10M

337.40M

Accounts Receivable

574.40M

552.50M

512.00M

507.40M

489.00M

385.30M

319.30M

288.20M

Inventory

443.90M

377.00M

434.70M

414.80M

378.40M

321.30M

235.70M

214.50M

Total Assets

4.27B

3.64B

3.83B

3.62B

3.31B

2.79B

2.34B

1.59B

Property, Plant & Equipment

1.84B

1.69B

1.51B

1.26B

1.13B

1.01B

909.40M

822.00M

Goodwill

110.00M

106.10M

108.50M

107.30M

109.90M

111.10M

107.80M

105.80M

Intangible Assets

7.70M

10.80M

15.10M

18.40M

23.00M

30.50M

29.80M

20.40M

Long-Term Investments

212.30M

202.10M

210.00M

204.90M

207.70M

214.70M

192.70M

91.20M

Total Current Liabilities

654.90M

550.40M

671.80M

519.00M

594.10M

503.40M

341.60M

283.70M

Accounts Payable

253.70M

239.30M

242.40M

215.40M

232.20M

213.10M

156.80M

130.40M

Short-Term Debt

22.70M

18.80M

134.00M

2.20M

44.20M

2.30M

100K

Total Liabilities

1.09B

961.10M

948.50M

931.90M

978.40M

939.30M

768.20M

582.60M

Long-Term Debt

298.40M

202.60M

72.80M

206.70M

208.80M

252.90M

255.00M

196.00M

Total Debt

416.70M

305.30M

309.00M

317.90M

325.30M

325.70M

329.30M

196.10M

Net Debt (Cash)

-374.60M

-179.30M

-544.90M

-576.40M

-437.30M

-289.80M

-109.80M

-141.30M

Total Shareholders' Equity

3.18B

2.68B

2.88B

2.68B

2.34B

1.85B

1.57B

1.40B

Common Stock

18.80M

Retained Earnings

4.37B

3.96B

3.52B

2.99B

2.46B

1.85B

1.55B

1.35B

Current Ratio

3.02

2.79

2.88

3.70

2.93

2.73

3.10

3.15

Debt to Equity Ratio

0.13

0.11

0.12

0.14

0.18

0.21

0.14

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)